VCG
Vantage Consulting Group’s HCA Healthcare HCA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-921
| Closed | -$296K | – | 78 |
|
2024
Q2 | $296K | Sell |
921
-54
| -6% | -$17.3K | 0.22% | 78 |
|
2024
Q1 | $325K | Sell |
975
-236
| -19% | -$78.7K | 0.21% | 71 |
|
2023
Q4 | $328K | Buy |
1,211
+8
| +0.7% | +$2.17K | 0.22% | 66 |
|
2023
Q3 | $296K | Sell |
1,203
-1
| -0.1% | -$246 | 0.2% | 90 |
|
2023
Q2 | $365K | Sell |
1,204
-170
| -12% | -$51.6K | 0.21% | 61 |
|
2023
Q1 | $362K | Sell |
1,374
-66
| -5% | -$17.4K | 0.21% | 74 |
|
2022
Q4 | $346K | Sell |
1,440
-220
| -13% | -$52.8K | 0.2% | 67 |
|
2022
Q3 | $305K | Sell |
1,660
-74
| -4% | -$13.6K | 0.18% | 78 |
|
2022
Q2 | $291K | Buy |
1,734
+515
| +42% | +$86.4K | 0.16% | 88 |
|
2022
Q1 | $306K | Sell |
1,219
-295
| -19% | -$74.1K | 0.12% | 94 |
|
2021
Q4 | $389K | Buy |
1,514
+175
| +13% | +$45K | 0.1% | 67 |
|
2021
Q3 | $325K | Buy |
1,339
+274
| +26% | +$66.5K | 0.07% | 83 |
|
2021
Q2 | $220K | Buy |
+1,065
| New | +$220K | 0.04% | 181 |
|
2021
Q1 | – | Sell |
-678
| Closed | -$112K | – | 720 |
|
2020
Q4 | $112K | Buy |
+678
| New | +$112K | 0.01% | 150 |
|